[1. A. C. Moffat, M. D. Osselton and B. Widdop, Clarke’s Analysis of Drugs and Poisons, Pharmaceutical Press, London 2011.]Search in Google Scholar
[2. L. L. Brunton, J. S. Lazo and K. L. Parker (Eds.), Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th ed., McGraw-Hill, New York 2006.10.1345/aph.1G685]Search in Google Scholar
[3. British Pharmacopoeia, Medicines and Healthcare Products Regulatory Agency (MHRA), London 2013.]Search in Google Scholar
[4. United States Pharmacopeia, United States Pharmacopeial Convention, Rockville 2011.]Search in Google Scholar
[5. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Sequential spectrophotometric method for the simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide in coformulated tablets, Int. J. Spectrosc. 2013 (2013) article ID 273102; DOI: 10.1155/2013/273102.10.1155/2013/273102]Search in Google Scholar
[6. D. Ramesh and M. Habibuddin, Stability indicating RP-HPLC method for the simultaneous determination of atorvastatin calcium, metformin hydrochloride, and glimepiride in bulk and combined tablet dosage form, Int. Schol. Res. Not. 2014 (2014) article ID 754695; DOI: 10.1155/2014/754695.10.1155/2014/754695489731527433531]Search in Google Scholar
[7. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Different approaches in partial least squares and artificial neural network models applied for the analysis of a ternary mixture of amlodipine, valsartan and hydrochlorothiazide, Spectrochim. Acta A 122 (2014) 744-750; DOI: 10.1016/j.saa.2013.11.045.10.1016/j.saa.2013.11.04524378624]Search in Google Scholar
[8. B. Ramesha, K. V. Reddy, B. Kishore, M. A. Kumar, L. Raju and B. Thara, Development and validation of a stability-indicating gradient RP-UHPLC method for the determination of impurities in atorvastatin drug substance, J. Liq. Chromatogr. Relat. Technol. 37 (2014) 275-297; DOI: 10.1080/10826076.2012.745135.10.1080/10826076.2012.745135]Search in Google Scholar
[9. A. A. Elshanawane, L. M. Abdelaziz, M. M. Kamal and H. M. Hafez, Quantitative determination of telmisartan, ramipril, amlodipine besylate, and atorvastatin calcium by HPLC, J. Liq. Chromatogr. Relat. Technol. 37 (2014) 195-206; DOI: 10.1080/10826076.2012.738622.10.1080/10826076.2012.738622]Search in Google Scholar
[10. E. S. Elzanfaly, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Continuous wavelet transform, a powerful alternative to derivative spectrophotometry in analysis of binary and ternary mixtures: A comparative study, Spectrochim. Acta A 151 (2015) 945-955; DOI: 10.1016/j.saa.2015.06.100.10.1016/j.saa.2015.06.10026186613]Search in Google Scholar
[11. M. M. Bkhaitan and A. Z. Mirza, Stability‐indicating HPLC‐DAD method for simultaneous determination of atorvastatin, irbesartan, and amlodipine in bulk and pharmaceutical preparations, Bull. Korean Chem. Soc. 36 (2015) 2230-2237; DOI: 10.1002/bkcs.10433.10.1002/bkcs.10433]Search in Google Scholar
[12. S. A. Hassan, E. S. Elzanfaly, M. Y. Salem and B. A. El-Zeany, Mean centering of double divisor ratio spectra, a novel spectrophotometric method for analysis of ternary mixtures, Spectrochim. Acta A 153 (2016) 132-142; DOI: 10.1016/j.saa.2015.07.109.10.1016/j.saa.2015.07.10926298680]Search in Google Scholar
[13. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeiny, Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of amlodipine and atorvastatin, Spectrochim. Acta A 83 (2011) 140-148; DOI: 10.1016/j.saa.2011.08.005.10.1016/j.saa.2011.08.00521908232]Search in Google Scholar
[14. Y. Zhou, J. Li, X. He, M. Jia, M. Liu, H. Li, Z. Xiong, Y. Fan and W. Li, Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study, J. Pharm. Biomed. Anal. 83 (2013) 101-107; DOI: 10.1016/j.jpba.2013.04.021.10.1016/j.jpba.2013.04.02123711572]Search in Google Scholar
[15. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Development and validation of Hpoint standard addition method applied for the analysis of binary mixture of amlodipine and atorvastatin, Int. J. Pharm. Bio Sci. 4 (2013) 230-243.]Search in Google Scholar
[16. A. Mohammadi, A. B. Moghaddam, K. Eilkhanizadeh, E. Alikhani, S. Mozaffari and T. Yavari, Electro-oxidation and simultaneous determination of amlodipine and atorvastatin in commercial tablets using carbon nanotube modified electrode, Micro Nano Lett. 8 (2013) 413-417; DOI: 10.1049/ mnl.2013.0080.10.1049/mnl.2013.0080]Search in Google Scholar
[17. B. A. Moussa, A. A. El-Zaher, M. A. Mahrouse and M. S. Ahmed, Simultaneous determination of amlodipine besylate and atorvastatin calcium in binary mixture by spectrofluorimetry and HPLC coupled with fluorescence detection, Anal. Chem. Insights 8 (2013) 107-115; DOI: 10.4137/ACI.S12921.10.4137/ACI.S12921382565024250220]Search in Google Scholar
[18. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Three different methods for determination of binary mixture of amlodipine and atorvastatin using dual wavelength spectrophotometry, Spectrochim. Acta A 104 (2013) 70-76; DOI: 10.1016/j.saa.2012.11.079.10.1016/j.saa.2012.11.07923266678]Search in Google Scholar
[19. P. Haritha, B. S. Rao and Y. Sunandamma, Method development and validation for simultaneous determination of amlodipine besylate and atorvastatin calcium by RP-HPLC technique, Asian J. Res. Chem. 7 (2014) 438-445.]Search in Google Scholar
[20. N . Ibrahim, M. Rizk, A. Ibrahim, S. Tawakkol and I. Ali, Simultaneous determination of amlodipine besylate and atorvastatin calcium by using spectrophotometric method with multivariate calibration and HPLC method implementing „design of experiment”, Int. J. Pharm. Pharm. Sci. 6 (2014) 419-425.]Search in Google Scholar
[21. A. L. Vonica-Gligor, T. Casian, A. Reznek, I. Tomuta and F. Gligor, Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry, Farmacia 63 (2015) 381-387.]Search in Google Scholar
[22. B. G. Chaudhari, N. M. Patel and P. B. Shah, Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products, Chem. Pharm. Bull. (Tokyo) 55 (2007) 241-246; DOI: 10.1248/cpb.55.241.10.1248/cpb.55.24117268096]Search in Google Scholar
[23. A. Mohammadi, N. Rezanour, M. Ansari Dogaheh, F. Ghorbani Bidkorbeh, M. Hashem and R. Walker, A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets, J. Chromatogr. B 846 (2007) 215-221; DOI: 10.1016/j.jchromb.2006.09.007.10.1016/j.jchromb.2006.09.00717010681]Search in Google Scholar
[24. D. Shah, K. Bhatt, R. Mehta, S. Baldania and T. Gandhi, Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations, Indian J. Pharm. Sci. 70 (2008) 754-760; DOI: 10.4103/0250-474X.49117.10.4103/0250-474X.49117304086921369436]Search in Google Scholar
[25. M. Hefnawy, M. Sultan and H. Al-Johar, Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations, J. Liq. Chromatogr. Relat. Technol. 32 (2009) 2923-2942; DOI: 10.1080/10826070903320681.10.1080/10826070903320681]Search in Google Scholar
[26. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products, Spectrochim. Acta A 154 (2016) 58-66; DOI: 10.1016/j.saa.2015.10.007.10.1016/j.saa.2015.10.00726513228]Search in Google Scholar
[27. A. A. Shirkhedkar and S. J. Surana, Simultaneous densitometric TLC analysis of atorvastatin calcium and fenofibrate in the bulk drug and in pharmaceutical formulations, J. Planar Chromatogr.- Mod. TLC 22 (2009) 355-358; DOI: 10.1556/JPC.22.2009.5.7.10.1556/JPC.22.2009.5.7]Search in Google Scholar
[28. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Nov 2005. ]Search in Google Scholar